Total Pageviews

Sunday, March 6, 2022

IVERMECTIN, THE INEXPENSIVE GENERIC DRUG OUTPERFORMS SUPER EXPENIVE FDA APPROVED REMDESIVIR

 In a recent peer reviewed study, from  Miami U.S., it is clear again beyond a shadow of a doubt that Ivermectin should have been the preferred drug of choice for a long, long time, but apparently, because of profit expectations, by BigPharma and friends, it was maligned every step of the way.  History may show that millions of people, in the world, were left to die without proper medical care, for the sake of profits all around.

I think it is best to let the renown Dr. John Campbell do the talking.  By following the link below, you can just do that.

https://www.youtube.com/watch?v=rfyOihhAD4A

This expensive money making machine, called Remdesivir (240 pounds per vial), is in fact a dangerous drug, according to some, to the point that some countries don't allow the usage of this drug, if my memory serves me right.  To my surprise, now even the

"WHO recommends against the use of remdesivir in COVID-19 patients"

"WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients."

https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients 

Miracles never seize to happen.

Needless to say, some unfortunate patients paid with their lives because this useless drug was used with Covid-19 patients, in lieu of Ivermectin and other existing off'-label drugs, which were more effective than Remdesivir.  The only thing this drug had over Ivermectin, and others was, it made big money.

The retail price of remdesivir in the U.S. was set by Gilead at $520 a dose. A typical treatment course requiring six or more doses costs thousands of dollars per patient.

https://www.npr.org/sections/goatsandsoda/2020/11/20/937018585/who-trial-finds-remdesivir-has-no-meaningful-effect-in-covid-19-patients 

 

1 comment:

  1. Steve Kirsch published some very sad vaccine statistics that are relevant to the topic of vaccine safety.

    "Steve Kirsch
    Executive Director, Vaccine Safety Research Foundation (vacsafety.org)"

    https://stevekirsch.substack.com/p/license-to-kill?utm_source=substack&utm_campaign=post_embed&utm_medium=email&s=r

    Thank you Dr. John Day for bringing this to my attention.

    ReplyDelete